---
schema_version: "secwatch.filing_event.v1"
accession: "0001323885-25-000098"
form_type: "8-K"
ticker: "ATRC"
cik: "0001323885"
company_name: "AtriCure, Inc."
filed_at: "2025-10-29T23:59:59+00:00"
generated_at: "2026-05-17T01:36:05.227948+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# AtriCure Q3 revenue +15.8% to $134.3M, net loss narrows to $0.3M; raises 2025 outlook

## Summary
- Revenue of $134.3M (+15.8% YoY); U.S. $109.3M (+14.5%), international $25.0M (+22.0%).
- Net loss of $0.3M ($0.01 diluted EPS) improves $7.6M YoY; adjusted EBITDA $17.8M (+$9.9M).
- Gross margin 75.5% (+59 bps) on favorable product mix; operating income $0.2M vs loss of $7.4M.
- Company raises full-year 2025 financial outlook (specific guidance numbers not disclosed in press release).

## SEC filing metadata
- accession: 0001323885-25-000098
- form_type: 8-K
- ticker: ATRC
- cik: 0001323885
- company_name: AtriCure, Inc.
- filed_at: 2025-10-29T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1323885/000132388525000098/0001323885-25-000098-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1323885/000132388525000098/atrc-20251029.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001323885-25-000098
- JSON: https://secwatch.observer/filing/0001323885-25-000098.json
- Plain text: https://secwatch.observer/filing/0001323885-25-000098.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.